← back to search

Anjum Khan

University of York · GB
Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Hematopoietic Stem Cell Transplantation, and Myeloproliferative Neoplasms: Diagnosis and Treatment.
h-index
16
citations
1,181
works
66
NIH funding
primary concept
Medicine
email

Recent publications

Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation
Science Advances 2025cited by 3position: middledoi
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT
Blood Advances 2024cited by 57position: middledoi
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS
Blood Neoplasia 2024cited by 34position: middledoi
Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy
Blood 2023cited by 63position: middledoi
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
Leukemia 2023cited by 47position: middledoi
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry
Frontiers in Immunology 2023cited by 25position: middledoi
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study
Blood 2022cited by 52position: middledoi
Molecular MRD status and outcome after transplantation in NPM1-mutated AML
Blood 2020cited by 164position: middledoi
PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement
Blood 2013cited by 240position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

N. George Mikhaeel · Guy's and St Thomas' NHS Foundation Trust1 papers (2013–2013)Andrew Macdonald · Queen's University1 papers (2025–2025)Karen Hogg · University of York1 papers (2025–2025)Andrew S. Mason · University of Edinburgh1 papers (2025–2025)Michael A. Carpenter · Howard Hughes Medical Institute1 papers (2025–2025)Tim P. Morris · London School of Hygiene & Tropical Medicine1 papers (2013–2013)Grace B. Hatton · Farr Institute1 papers (2025–2025) · 1 papers (2025–2025)Richard T. Gawne · University of York1 papers (2025–2025)Robert Carr · The US Oncology Network1 papers (2013–2013)Simon C. Baker · University of York1 papers (2025–2025) · 1 papers (2013–2013) · 1 papers (2025–2025)Parisa Boukani · Center for Cancer Research1 papers (2025–2025)Sally James · London School of Hygiene & Tropical Medicine1 papers (2025–2025) · 1 papers (2025–2025)Gabriel J. Starrett · Center for Cancer Research1 papers (2025–2025)Helena Vogel · University of California, Davis1 papers (2025–2025)Iñigo Martincorena · Wellcome Sanger Institute1 papers (2025–2025)Jennifer Southgate · University of York1 papers (2025–2025)